Parents of children who have attention deficit hyperactivity disorder (ADHD) require lessons on how to cope with the behaviour of their youngsters, it has been asserted.

The UK's National Institute for Health and Clinical Excellence (NICE) states drugs should be avoided and not given to youngsters under the age of five.

Continuing, the body suggests teachers would also reap benefits from training to help them recognise and help children affected by the condition, the BBC reports.

Dr Tim Kendall, a consultant physician for Sheffield, also in the UK, tells the news provider there is an "over-reliance" on medicines.

"Quite commonly, people tend to revert to offering methylphenidate or atomoxetene. When they do that it's not always [good] because there's a good balance of risk and benefits," he adds.

Concluding, Dr Kendall asserts it is important to diagnose ADHD correctly, rather than label all unruly behaviour as being symptomatic of the condition.

Login and visit the ADHD Knowledge Centre

• Study dismisses sugar as encouraging hyperactivity 18/12/08
• ADHD symptoms may affect ability to quit smoking, study suggests 24/11/08
• ADHD drugs' genetic damage fears allayed in new study 21/11/08
• Movement study shows difference in sexes for ADHD sufferers 04/11/08
• ADHD and serious nicotine addiction risk 24/10/08

• CONCERTA XL Prolonged-release Tablets - 49.42%
  CONCERTA® XL is indicated as part of a comprehensive treatment programme for Attention Deficit Hyperactivity Disorder (ADHD) in children (over 6 years of age) and adolescents when remedial measures alone prove insufficient. Diagnosis must be made according to DSM-IV criteria or the guidelines in ICD ...
  
  
• EQUASYM Tablets - 47.03%
  Methylphenidate is indicated as part of a comprehensive treatment programme for attention-deficit hyperactivity disorder (ADHD) in children over 6 years of agewhen remedial measures alone prove insufficient. The decision to treat as well as follow-up must be under supervision of a specialist in ...
  
  
• EQUASYM XL Capsules - 46.1%
  Equasym XL is indicated as part of a comprehensive treatment programme for attention-deficit/hyperactivity disorder (ADHD) in children over 6 years of age when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders ...
  
  
• STRATTERA - 46.1%
  Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in children of 6 years and older and in adolescents as part of a comprehensive treatment programme. Diagnosis should be made according to DSM-IV criteria or the guidelines in ICD-10. Additional information ...
  
  
• RITALIN - 46.1%
  Indicated for the treatment of Attention-deficit Hyperactivity Disorder. (ADHD ...
  
  
• DEXEDRINE - 46.1%
  Narcolepsy; refractory hyperkinetic states in children under specialist supervision. (ADHD ...